Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Haefaa Alchalby"'
Autor:
Haefaa Alchalby, Peter Bannas, Nicolaus Kröger, Francis Ayuk, Frank M. Bengel, Hans Kreipe, Thorsten Derlin, Azien Laqmani, Ioanna Triviai
Publikováno v:
Journal of Nuclear Medicine. 57:1556-1559
1556 Objectives Widespread adoption of new imaging technologies requires that diagnostic performance is maintained as technology migrates from expert sites into general use. This Blinded Independent Evaluation (BIE) study was designed to demonstrate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cae6cf36e2e468edbd5fd68878fb4de1
https://doi.org/10.2967/jnumed.115.166348
https://doi.org/10.2967/jnumed.115.166348
Autor:
Kais Hussein, Hans Kreipe, Nicolaus Kröger, Angelika Stucki-Koch, Ioanna Triviai, Haefaa Alchalby
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:644-650
The only curative therapy for primary myelofibrosis (PMF) is allogeneic stem cell transplantation (ASCT). However, although we know that patients can benefit from ASCT, we do not know the extent of the changes of the expression profile of cytokines a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f4bef1df39ca1528db3693d9ef40ac
https://doi.org/10.1016/j.bbmt.2015.12.006
https://doi.org/10.1016/j.bbmt.2015.12.006
Autor:
Nicolaus Kröger, Haefaa Alchalby
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 14:S36-S41
Primary myelofibrosis is one of the Philadelphia chromosome-negative myeloproliferative neoplasms and is the member of that group with the worst survival and the most significant limitations in quality of life. Hepatosplenomegaly due to extramedullar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fe3981ae8e4a7c8b850768941439e6
https://doi.org/10.1016/j.clml.2014.06.012
https://doi.org/10.1016/j.clml.2014.06.012
Autor:
Didier Blaise, Michael Lioznov, Roberto Crocchiolo, Catherine Faucher, Boris Calmels, Thomas Stübig, Francis Ayuk, Nicolaus Kröger, Marie Luise Reckhaus, Jean El-Cheikh, Christine Wolschke, Ulrike Bacher, Claude Lemarie, Evgeny Klyuchnikov, Haefaa Alchalby, Sabine Furst, Andreas Sputtek, Christian Chabannon
Publikováno v:
Biology of Blood and Marrow Transplantation. 20:382-386
We retrospectively analyzed outcomes of a CD34(+)-selected stem cell boost (SCB) without prior conditioning in 32 patients (male/22; median age of 54 years; range, 20 to 69) with poor graft function, defined as neutrophils ≤1.5 x 10(9)/L, and/or pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89010ef9900a5e31691e5e85373a4767
https://doi.org/10.1016/j.bbmt.2013.11.034
https://doi.org/10.1016/j.bbmt.2013.11.034
Autor:
Arnold Kloos, Ulrich Lehmann, Christian Thiede, Anuhar Chaturvedi, Birgit Markus, U. Platzbecker, V Panagiota, Matthias Eder, Haefaa Alchalby, N Kröger, Arne Trummer, Felicitas Thol, Arnold Ganser, Gudrun Göhring, Anita Badbaran, Brigitte Schlegelberger, Tobias Schroeder, Michael Koenigsmann, H-H Kreipe, Boris Fehse, Christian Koenecke, Michael Stadler, Guido Kobbe, Rabia Shahswar, Michael Heuser
Publikováno v:
Leukemia. 28:1552-1555
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c425e91aa761a8375a325d0b7d5a0c5
https://doi.org/10.1038/leu.2014.66
https://doi.org/10.1038/leu.2014.66
Autor:
Haefaa Alchalby, Nicolaus Kröger, Christine Wolschke, Heinrich Lellek, Axel R. Zander, Ulrike Bacher, Ronja Veit, Tatjana Zabelina, Francis Ayuk, Lara Bussmann
Publikováno v:
Annals of Hematology. 93:855-861
In a retrospective single-centre study, we analysed the prognostic impact of factors identifiable at initial diagnosis of acute GVHD (aGVHD). We retrospectively analysed 495 adult patients of whom 308 (62 %) developed acute GVHD (I-IV) and were inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::240d1d80bd4458728964e8f238f28d7c
https://doi.org/10.1007/s00277-013-1957-0
https://doi.org/10.1007/s00277-013-1957-0
Autor:
Pein Um, Raissa Adjallé, Jürgen Berger, Randenborgh A, Heinrich Lellek, Christine Wolschke, Haefaa Alchalby, F Wortmann, Tatjana Zabelina, Axel R. Zander, Gitta Amtsfeld, N Kröger, F Ayuk, Evgeny Klyuchnikov, Schumacher S
Publikováno v:
Bone Marrow Transplantation. 49:126-130
To investigate the impact of anti-lymphocyte globulin (ATG-Fresenius) as part of the HLA-sibling transplantation, we evaluated 238 patients (median age 48 years) with different diagnoses (AML, ALL, CML and lymphoproliferative disorders). A total of 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd4c8978dea18025a30c33181ab559b
https://doi.org/10.1038/bmt.2013.143
https://doi.org/10.1038/bmt.2013.143
Autor:
Boris Fehse, Silke Zeschke, Francis Ayuk, Axel R. Zander, Djordje Atanackovic, Thomas Stübig, Tatjana Zabelina, Christine Wolschke, Anita Badbaran, Nicolaus Kröger, Ulrike Bacher, Haefaa Alchalby, Evgeny Klyuchnikov, Timon Hansen, Georgia Schilling, Marion Heinzelmann, Sabine Schwarz
Publikováno v:
Biology of Blood and Marrow Transplantation. 19(3):398-404
Within a prospective protocol, the incidence and impact of achievement of molecular remission (mCR) and high-risk cytogenetics was investigated in 73 patients with multiple myeloma (MM) after autologous (auto)–allogeneic (allo) tandem stem cell tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c41b319ac78068c4ca44703af8964b16
Autor:
Tatjana Zabelina, Ulrike Bacher, Francis Ayuk, Haefaa Alchalby, Christine Wolschke, F Wortmann, Heinrich Lellek, Axel R. Zander, N Kröger
Publikováno v:
Bone Marrow Transplantation. 48:1028-1032
In a retrospective study of 168 patients with AML in CR who underwent allo-SCT, we compare the impact of young unrelated donors (UD) vs older matched related donors (MRD) on 5-year OS (5-yr OS). Median follow-up was 59 months and median donor age was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d01e0a6c9ffb1c0063ad047458ad9306
https://doi.org/10.1038/bmt.2013.14
https://doi.org/10.1038/bmt.2013.14
Autor:
Heinrich Lellek, Ulrike Bacher, Francis Ayuk, Nicolaus Kröger, Maximilian Christopeit, A A Oyekunle, Philippe Schafhausen, Thomas Stübig, Ingo Müller, Haefaa Alchalby, Mascha Binder, Tatjana Zabelina, Christine Wolschke, Axel R. Zander
Publikováno v:
Annals of Hematology. 92:487-496
The introduction of tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) led to a dramatic change in the role of allogeneic stem cell transplantation (SCT) with a rapid decline in the number of patients receiving SCT in first chronic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb7e8917e0b63579bc9cfd9949df2f26
https://doi.org/10.1007/s00277-012-1650-8
https://doi.org/10.1007/s00277-012-1650-8